Patent · US Active

Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound

US8969400B2 · kind B2 · utility

4Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2008
Grant dateMar 3, 2015
Priority date
Expiry dateApr 25, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to novel pharmaceutical compositions comprising a therapeutically effective amount of a slow-release formulation of 5-hydroxytryptophan (5-HTP) and a serotonin-enhancing compound. The pharmaceutical compositions for use according to the invention are contemplated particularly useful for combating CNS disorders, including depressive disorders, bipolar disorders, anxiety disorders, obesity and pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.